Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

NCT01801670 · clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Enrollment was too slow, so no participants were ever enrolled.

Conditions

Interventions

Sponsor

Boston University

Collaborators